balance equationreview2025-03-31
Difference 8394000 exceeds tolerance 7998391.000. Presentation or filing-vintage differences need review.
Revenue
$181.85M
Fiscal year ended 2026-03-31Operating income
Unavailable
Fiscal year ended 2026-03-31Free cash flow
Unavailable
Fiscal year ended 2026-03-31Hudson Pacific Properties, Inc. (HPP) reported revenue of $181.85M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Hudson Pacific Properties, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Real Estate.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $181.85M | $256.03M | $186.62M | $190.00M | $198.46M | $209.67M | $200.39M | $218.00M | $214.02M | $223.42M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $80.32M | $153.56M | $82.66M | $81.95M | $85.20M | $93.74M | $85.55M | $104.74M | $103.97M | $107.88M |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 64.46M | Unavailable | shares 451.03M | shares 202.67M | shares 20.20M | Unavailable | shares 141.23M | shares 141.18M | shares 141.12M | Unavailable |
| Pretax income | -$50.56M | -$281.12M | -$144.06M | -$87.31M | -$80.08M | -$174.53M | -$104.83M | -$47.05M | -$53.36M | -$82.57M |
| Income tax expense | $348.00K | -$945.00K | $24.00K | $454.00K | $194.00K | -$1.05M | $2.18M | $510.00K | $0 | $6.08M |
| Diluted EPS | $-0.82 | Unavailable | $-0.30 | $-0.41 | $-3.70 | Unavailable | $-0.69 | $-0.33 | $-0.37 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $12.58M | $12.98M | $13.71M | $27.78M | $18.48M | $19.49M | $19.54M | $20.70M | $19.71M | $19.78M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $138.01M | $138.36M | $190.44M | $236.02M | $86.47M | $63.26M | $90.69M | $78.46M | $114.30M | $100.39M |
| Total assets | $7.23B | $7.27B | $7.80B | $8.13B | $8.00B | $8.13B | $8.32B | $8.35B | $8.25B | $8.28B |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $4.08B | $4.06B | $4.31B | $4.44B | $4.90B | $4.95B | $4.97B | $4.90B | $4.80B | $4.72B |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $3.09B | $3.15B | $3.43B | $3.63B | $3.04B | $3.12B | $3.29B | $3.40B | $3.39B | $3.49B |
| Temporary (mezzanine) equity | $49.88M | $50.58M | $49.27M | $48.89M | $48.38M | $49.28M | $50.17M | $51.14M | $52.11M | $57.18M |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $14.12M | $14.92M | $14.08M | $13.45M | $11.45M | $14.50M | $14.98M | $18.25M | $23.98M | $24.61M |
| Goodwill | $8.75M | $8.75M | $156.53M | $156.53M | $156.53M | $156.53M | $264.14M | $264.14M | $264.14M | $264.14M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $44.29M | $59.30M | $33.18M | -$2.04M | $30.54M | $162.00K | $63.74M | $35.62M | $65.13M | $9.22M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$34.31M | $106.94M | -$56.02M | -$24.02M | $15.94M | -$54.78M | -$74.73M | -$49.67M | -$71.36M | $592.35M |
| Financing cash flow | -$9.67M | -$218.56M | -$29.84M | $159.26M | -$11.73M | $39.86M | $24.98M | -$19.58M | $20.65M | -$576.50M |
| Net change in cash | Unavailable | Unavailable | -$52.68M | $133.20M | $34.75M | Unavailable | $14.00M | -$33.63M | $14.42M | $25.06M |
| Stock-based compensation | $1.94M | $3.79M | $3.58M | $17.89M | $5.14M | $6.56M | $5.96M | $6.92M | $6.57M | $6.78M |
| Common dividends paid | $557.00K | -$2.00K | $0 | $0 | $353.00K | $0 | $0 | $7.51M | $7.87M | $0 |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 | $0 | $0 | $0 |
| Depreciation & amortization | $80.72M | $93.05M | $94.08M | $94.75M | $93.08M | $89.10M | $86.67M | $86.80M | $91.85M | $103.19M |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 44.2% | 60.0% | 44.3% | 43.1% | 42.9% | 44.7% | 42.7% | 48.0% | 48.6% | 48.3% |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.1% | 1.5% | 1.9% | 9.4% | 2.6% | 3.1% | 3.0% | 3.2% | 3.1% | 3.0% |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | -8.4% | 22.1% | -6.9% | -12.8% | -7.3% | -6.2% | -13.4% | -11.1% | -15.2% | -17.2% |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HPP in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
10-K · Filed 2025-02-25View SEC filing
Reconciliation checks needing review
12 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2024-12-31
Difference 9815000 exceeds tolerance 8132239.000. Presentation or filing-vintage differences need review.
balance equationreview2024-09-30
Difference 9815000 exceeds tolerance 8317392.000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-30
Difference 9815000 exceeds tolerance 8352782.000. Presentation or filing-vintage differences need review.
balance equationreview2024-03-31
Difference 9815000 exceeds tolerance 8251462.000. Presentation or filing-vintage differences need review.
balance equationreview2023-12-31
Difference 9815000 exceeds tolerance 8282050.000. Presentation or filing-vintage differences need review.
balance equationreview2023-09-30
Difference 9815000 exceeds tolerance 8986802.000. Presentation or filing-vintage differences need review.
balance equationreview2023-06-30
Difference 9815000 exceeds tolerance 9105829.000. Presentation or filing-vintage differences need review.
balance equationreview2023-03-31
Difference 9815000 exceeds tolerance 9124091.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 9815000 exceeds tolerance 9319140.000. Presentation or filing-vintage differences need review.
balance equationreview2022-09-30
Difference 9815000 exceeds tolerance 9320419.000. Presentation or filing-vintage differences need review.
balance equationreview2022-06-30
Difference 9815000 exceeds tolerance 9050638.000. Presentation or filing-vintage differences need review.